Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Craig K. Esser is active.

Publication


Featured researches published by Craig K. Esser.


Bioorganic & Medicinal Chemistry Letters | 2000

Substituted 2-aminopyridines as inhibitors of nitric oxide synthase

Craig K. Esser; William K. Hagmann; William F. Hoffman; Shrenik K. Shah; Kenny K. Wong; Renee M. Chabin; Ravindra K. Guthikonda; Malcolm Maccoss; Charles G. Caldwell; Philippe L. Durette

A series of substituted 2-aminopyridines was prepared and evaluated as inhibitors of human nitric oxide synthases (NOS). 4,6-Disubstitution enhanced both potency and specificity for the inducible NOS with the most potent compound having an IC50 of 28 nM.


Bioorganic & Medicinal Chemistry Letters | 1995

Inhibition of matrix metalloproteinases by N-carboxyalkyl dipeptides: Enhanced potency and selectivity with substituted P1′ homophenylalanines

Soumya P. Sahoo; Charles G. Caldwell; Kevin T. Chapman; Philippe L. Durette; Craig K. Esser; Ihor E. Kopka; Scott A. Polo; Kelly M. Sperow; Lisa M. Niedzwiecki; Maria Izquierdo-Martin; Benedict Chang; Richard K. Harrison; Ross L. Stein; Malcolm Maccoss; William K. Hagmann

Abstract A series of N-carboxyalkyl dipeptides were synthesized to evaluate their inhibitory activities against human stromelysin-1(MMP-3), collagenase(MMP-1), and gelatinase-A(MMP-2). Structures with a homophenylalanine residue at P 1′ substituted at the para position with small alkyl groups are potent inhibitors of (MMP-3) and (MMP-2) (K i′ s 2–40 nM), but weak inhibitors of (MMP-1).


Bioorganic & Medicinal Chemistry Letters | 1997

Solid-phase synthesis of a N-carboxyalkyl tripeptide combinatorial library

Craig K. Esser; Nancy J. Kevin; Nathan A. Yates; Kevin T. Chapman

Abstract A combinatorial library of N-carboxyalkyl tripeptides was prepared to generate new leads against metalloproteinases. Using the base labile TentaGel S HMB resin, an Fmoc strategy was employed to yield 100 mixtures of 200 compounds each of the general structure 5. A synthetic protocol combining both mix and split and indexed combinatorial strategies was used, and selected inhibition data against MMP-3 is reported.


Bioorganic & Medicinal Chemistry Letters | 2011

The discovery of high affinity agonists of GPR109a with reduced serum shift and improved ADME properties

Jason E. Imbriglio; Daniel A. DiRocco; Rena Bodner; Subharekha Raghavan; Weichun Chen; Daria Marley; Craig K. Esser; Tom G. Holt; Michael Wolff; Andrew K.P. Taggart; M. Gerard Waters; James R. Tata; Steven L. Colletti

Amino-anthranilic acid derivatives have been identified as a new class of low serum shifted, high affinity full agonists of the human orphan G-protein-coupled receptor GPR109a with improved ADME properties.


Bioorganic & Medicinal Chemistry Letters | 2009

GPR109a agonists. Part 1: 5-Alkyl and 5-aryl-pyrazole–tetrazoles as agonists of the human orphan G-protein coupled receptor GPR109a

Jason E. Imbriglio; Sookhee Chang; Rui Liang; Subharekha Raghavan; Darby Schmidt; Abby Smenton; Scott Tria; Thomas O. Schrader; Jae-Kyu Jung; Craig K. Esser; Andrew K.P. Taggart; Kang Cheng; Ester Carballo-Jane; M. Gerard Waters; James R. Tata; Steven L. Colletti

5-Alkyl and aryl-pyrazole-tetrazoles have been identified as a new class of selective, small-molecule, agonists of the human G-protein-coupled receptor GPR109a, a high affinity receptor for the HDL-raising drug nicotinic acid.


Tetrahedron Letters | 1999

Synthesis of di- and trisubstituted guanidines on multivalent soluble supports

Jiang Chang; Oyinda Oyelaran; Craig K. Esser; Gary S. Kath; Gregory W. King; Brian Uhrig; Zenon Konteatis; Ronald M. Kim; Kevin T. Chapman

Abstract A library of 48 di- and trisubstituted guanidines was synthesized on a soluble, tetravalent support. Support-bound intermediates and cleaved products were isolated in parallel by size exclusion chromatography using a semiautomated system. Products were generally obtained in good yield and purity.


Bioorganic & Medicinal Chemistry Letters | 2010

GPR109a agonists. Part 2: Pyrazole-acids as agonists of the human orphan G-protein coupled receptor GPR109a

Jason E. Imbriglio; Sookhee Chang; Rui Liang; Subharekha Raghavan; Darby Schmidt; Abby Smenton; Scott Tria; Thomas O. Schrader; Jae-Kyu Jung; Craig K. Esser; Tom G. Holt; Michael Wolff; Andrew K.P. Taggart; Kang Cheng; Ester Carballo-Jane; M. Gerard Waters; James R. Tata; Steven L. Colletti

5-Alkyl and aryl-pyrazole-acids have been identified as a new class of selective, small-molecule, agonists of the human orphan G-protein-coupled receptor GPR109a, a high affinity receptor for the HDL-raising drug nicotinic acid.


Protein Science | 1995

Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.

Joseph W. Becker; Alice I. Marcy; Laura Rokosz; Melinda G. Axel; Jonathan J. Burbaum; Paula M. D. Fitzgerald; Patricia M. Cameron; Craig K. Esser; William K. Hagmann; Jeffrey D. Hermes; James P. Springer


Nature Structural & Molecular Biology | 1994

The NMR structure of the inhibited catalytic domain of human stromelysin-1.

Paul R. Gooley; John F. O'Connell; Alice I. Marcy; Gregory C. Cuca; Scott P. Salowe; Bruce L. Bush; Jeffrey D. Hermes; Craig K. Esser; William K. Hagmann; James P. Springer; Bruce A. Johnson


Journal of Medicinal Chemistry | 1993

Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides

Kevin T. Chapman; Ihor E. Kopka; Philippe L. Durette; Craig K. Esser; Thomas J. Lanza; Izquierdo-Martin M; Lisa M. Niedzwiecki; Benedict Chang; Richard K. Harrison; Kuo Dw

Collaboration


Dive into the Craig K. Esser's collaboration.

Researchain Logo
Decentralizing Knowledge